Drug-resistant cancer responds to personalized drug combinations

Drug-resistant cancer responds to personalized drug combinations

Cancer researcher and physician Jeffrey Engelman of the Massachusetts General Hospital in Boston has found a promising way of treating drug-resistant cancer by growing patients’ tumor cells and testing various drug combinations on them to find a way of effective treatment. Engelman and his colleagues devised a way to culture lung cancer cells from patient samples and then test them against a battery of 76 different drugs; and they got encouraging results. Continue reading Drug-resistant cancer responds to personalized drug combinations